USPTO serial 76226929
MAYBRIDGE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 15, 2005
- Examiner
- SOUDERS, MICHAEL J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with MAYBRIDGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenya L. Williams
Kenya L. Williams Thermo Fisher Scientific Inc.5823 Newton DriveCarlsbad, CA 92008United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals for use in the manufacture of medicines, pharmaceuticals, agrochemicals, industrial agents, adhesives, paints, cosmetics and lubricants; chemicals for use in coating pharmaceutical products; ] chemical reagents for scientific or medical research; [ catalysts for use in laboratory experiments; mineral substances in the nature of filtering materials for use in laboratory experiments; ] reactive intermediate chemicals for use in the pharmaceutical, biotechnology, agrochemical and veterinary industries; chemicals and chemical intermediates for use in research in the field of medicines, pharmaceuticals, [ biochemicals, ] agrochemicals, [ industrial agents, adhesives and lubricants; surface active compounds for general use in the industrial arts, namely, as wetting, spreading, emulsifying, solublising, dispersing and penetrating agents; polymers for use in the field of producing medicines, pharmaceuticals, biochemicals, agrochemicals, industrial agents, chemical intermediates, adhesives, paints, cosmetics and lubricants; unprocessed synthetic and artificial resins for use in the field of producing medicines, pharmaceuticals, biochemicals, agrochemicals, industrial reagents, chemical intermediates, adhesives, paints, cosmetics and lubricants; ] chemical substances used in the field of analysis in laboratories; [ chemicals used in the field of industrial and agricultural diagnosis and screening; ] organic chemical compounds and intermediates for use in the industrial, agrochemical and pharmaceutical arts, and research; [ enzymes and enzyme preparations for use in the industrial, agrochemical and pharmaceutical arts, and research; screening compounds; DNA, RNA, and proteins used in the field of production of chemicals for medical agriculture and veterinary purposes; amino acids for laboratory or research use; alcohols, aldehydes, alkalies, alkaloids, alginates, amines, amides, anhydrides, bromine, carbides, chlorides, dextrins, ethers, halides, imides, iodides, ketones, oxides, sulphides, pepsins, peptones, peptides, phenols, silicates, thiols, nitro derivatives, nitrates, nitrides, nitriles, lanthanums and actinums, for use in the manufacture of pharmaceutical preparations; absorbing carbons for use in the manufacture of pharmaceuticals; botanical extracts, namely, plant and yeast extracts for use in making pharmaceuticals ] | ACTIVE | — |
| 005 | [ Diagnostic reagents for clinical or medical laboratory use; diagnostic preparations for clinical laboratory and screening use; hormones for medicinal and diagnostic use; pharmaceutical preparations, namely, immunosuppressive agents; and amino acids for medicinal and diagnostic purposes ] | SECTION 8 - CANCELLED | — |
| 042 | [ Research, analysis and development of new substances and chemical intermediates for others relating to chemistry, bacteriology, medicines, veterinary products, sanitary products, agriculture and horticulture; chemical analysis and analytical examinations; chemical engineering services; providing an online electronic database in the field of chemicals, chemical products, chemical reagents, chemical intermediates, pharmaceuticals and medicines; research relating to chemicals, chemical products, chemical reagents, chemical intermediates, pharmaceuticals, medicines, biotechnology compounds, DNA and RNA fragments, proteins and enzymes used in the production of pharmaceutical, industrial and agrochemical compounds and products, medicines, veterinary products, and sanitary products; design, analysis and development for others of new substances and intermediates in the field of chemicals, chemical compounds, chemical products, chemical reagents, chemical intermediates, pharmaceuticals, medicines, biotechnology compounds, DNA and RNA fragments, proteins and enzymes; designing and developing processes for others to use in the production of pharmaceutical industrial and agricultural compounds, chemicals, chemical products, chemical reagents, chemical intermediates, pharmaceuticals, medicines, biotechnology compounds, DNA and RNA fragments, proteins and enzymes; research and development of new substances for others in the field of pharmaceuticals, medicines and agrochemicals; design for others in the field of pharmaceutical an agrochemical research; design for others in the field of industrial plants and processes used in the production of pharmaceutical industrial and agricultural compounds, chemicals, chemical products, chemical reagents, chemical intermediates, pharmaceuticals, medicines, biotechnology compounds, DNA and RNA fragments, proteins and enzymes; research and development of new substances for others in the field of pharmaceuticals, medicines, industrial chemicals and agrochemicals; computer software design and maintenance for others for use in the field of designing and producing pharmaceutical industrial and agricultural compounds, chemicals, chemical products, chemical reagents, chemical intermediates, pharmaceuticals, medicines, biotechnology compounds, DNA and RNA fragments, proteins and enzymes; technical consultation in the field of pharmaceutical industrial and agricultural compounds, chemicals, chemical products, chemical reagents, chemical intermediates, pharmaceuticals, medicines, biotechnology compounds, DNA and RNA fragments, proteins and enzymes; providing information via the Internet in the field of pharmaceutical industrial and agricultural compounds, chemicals, chemical products, chemical reagents, chemical intermediates, pharmaceuticals, medicines, biotechnology compounds, DNA and RNA fragments, proteins and enzymes ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Maybridge Plc.
- Other trademarks owned by Maybridge Plc.
- Other trademarks owned by Maybridge Plc.
- Other trademarks owned by Maybridge Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MAYBRIDGE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2025 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Aug 1, 2025 | RNL2 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Aug 1, 2025 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Aug 1, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 12, 2025 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 15, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jun 23, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Mar 23, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Mar 25, 2015 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Mar 25, 2015 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Mar 25, 2015 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Mar 25, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 10, 2015 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 24, 2011 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 23, 2011 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 17, 2011 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Mar 17, 2011 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 15, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 7, 2004 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Dec 7, 2004 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Nov 24, 2004 | PAPER RECEIVED | — | |
| Sep 28, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 6, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 16, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 22, 2004 | 44DD | SEC. 44(D) CLAIM DELETED | — |
| Apr 7, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2003 | CFIT | CASE FILE IN TICRS | — |
| Dec 1, 2003 | PAPER RECEIVED | — | |
| Nov 12, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 10, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 10, 2003 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2003 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 10, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2003 | PAPER RECEIVED | — | |
| Dec 5, 2002 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| May 2, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jan 24, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 20, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2001 | DOCK | ASSIGNED TO EXAMINER | — |